Jingwen Si

机构：Tongji University, Tianjin Central Hospital of Gynecology Obstetrics, Tsinghua University · ORCID：0000-0003-3188-7567

发表论文 29 篇 · 总被引 483 次 · h-index 10

代表论文

• Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies (2020 · Cancer Cell · 被引 191)
• Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade (2020 · Science Translational Medicine · 被引 51)
• Modeled microgravity suppressed invasion and migration of human glioblastoma U87 cells through downregulating store-operated calcium entry (2015 · Biochemical and Biophysical Research Communications · 被引 41)
• Adverse Drug Reaction Discovery Using a Tumor-Biomarker Knowledge Graph (2021 · Frontiers in Genetics · 被引 23)
• miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas. (2015 · PubMed · 被引 21)
• Decreasing HPK1 expression in CD19 CAR-T cells: A novel strategy to overcome challenges of cell therapy for adult (r/r) B-ALL. (2022 · Journal of Clinical Oncology · 被引 11)